Log In
Print this Print this

formerly BB-HB-331

  Manage Alerts
Collapse Summary General Information
Company Benitec Biopharma Ltd.
DescriptionDNA-directed RNA interference therapy
Molecular Target
Mechanism of Action 
Therapeutic Modality 
Latest Stage of DevelopmentPreclinical
Standard IndicationHepatitis B virus (HBV)
Indication DetailsTreat hepatitis B virus (HBV)
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today